TdC 184: Tratamento medicamentoso para Demências: anticolinesterásicos, novas drogas e BPSD
Descrição e referências
🚨 www.tadeclinicagem.com.br/guia - Conheça o Guia TdC com 7 dias grátis 🚨
Raphael Coelho e João Urbano (Joca) convidam Caio Lima para uma conversa sobre o tratamento medicamentoso das demências. Quais são as principais drogas? Quais são os novos medicamentos vindo por aí? Como manejar os sintomas da dêmencia (BPSD)? Tudo isso nesse episódio!
Referências:
1. XU, Hong et al. Long-term effects of cholinesterase inhibitors on cognitive decline and mortality. Neurology, v. 96, n. 17, p. e2220-e2230, 2021.
2. CARAMELLI, Paulo et al. Tratamento da demência: recomendações do Departamento Científico de Neurologia Cognitiva e do Envelhecimento da Academia Brasileira de Neurologia. Dementia & Neuropsychologia, v. 16, p. 88-100, 2022.
3. CUMMINGS, Jeffrey et al. Reduction and prevention of agitation in persons with neurocognitive disorders: an international psychogeriatric association consensus algorithm. International Psychogeriatrics, p. 1-12, 2023.
4. SCHELTENS, Philip et al. Alzheimer's disease. The Lancet, v. 388, n. 10043, p. 505-517, 2016.
5. LIVINGSTON, Gill et al. Dementia prevention, intervention, and care. The lancet, v. 390, n. 10113, p. 2673-2734, 2017.
6. ARVANITAKIS, Zoe; SHAH, Raj C.; BENNETT, David A. Diagnosis and management of dementia. Jama, v. 322, n. 16, p. 1589-1599, 2019.
7. SORBI, Sa et al. EFNS‐ENS Guidelines on the diagnosis and management of disorders associated with dementia. European Journal of Neurology, v. 19, n. 9, p. 1159-1179, 2012.
8. Uptodate 2022. Cholinesterase inhibitors in the treatment of dementia. Authors:Daniel Press, MDMichael Alexander, MDSection Editors:Steven T DeKosky, MD, FAAN, FACP, FANAKenneth E Schmader, MDDeputy Editor:Janet L Wilterdink, MD
9. Uptodate 2023. Treatment of Alzheimer disease. Authors:Daniel Press, MDStephanie S Buss, MDSection Editors:Steven T DeKosky, MD, FAAN, FACP, FANAKenneth E Schmader, MDDeputy Editor:Janet L Wilterdink, MD
10. VAN DYCK, Christopher H. et al. Lecanemab in early Alzheimer’s disease. New England Journal of Medicine, 2022.
11. KALES, Helen C.; GITLIN, Laura N.; LYKETSOS, Constantine G. Assessment and management of behavioral and psychological symptoms of dementia. Bmj, v. 350, 2015.